Tell us about your search experience on the TGA website - complete our short survey

AusPAR: Mogamulizumab

Australian Public Assessment Report

AusPAR

AusPAR: Mogamulizumab [PDF, 1.07 MB]

AusPAR: Mogamulizumab [Word, 1.65 MB]

Attachment: Product Information: Mogamulizumab [PDF, 309.3 KB]

Attachment: Product Information: Mogamulizumab [Word, 251.15 KB]

Device/Product Name

Poteligeo

Active ingredients

Mogamulizumab

AusPAR Date

27 April 2021

Published

10 May 2021

Submission Number

PM-2020-00700-1-6

Submission Type

New biological entity

Decision

Approved